Prosecution Insights
Prosecution Insights
6 pending office actions • 2 clients • 6 examiners • 6 art units • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JACKSON, JORDAN L | 1 | 40.8% | +38.5% |
| TSAI, TSUNG YIN | 1 | 81.7% | +11.0% |
| SORRIN, AARON JOSEPH | 1 | 75.8% | +45.5% |
| WINDSOR, COURTNEY J | 1 | 86.5% | +8.7% |
| GEBRESLASSIE, WINTA | 1 | 75.6% | +25.0% |
| RUDDIE, ELLIOT S | 1 | 65.5% | +42.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18536174 | HIERARCHICAL WORKFLOW FOR GENERATING ANNOTATED TRAINING DATA FOR MACHINE LEARNING ENABLED IMAGE SEGMENTATION | TSAI, TSUNG YIN | 107d overdue |
| 18482237 | TREATMENT OUTCOME PREDICTION FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION USING BASELINE CHARACTERISTICS | WINDSOR, COURTNEY J | 31d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18536174 | HIERARCHICAL WORKFLOW FOR GENERATING ANNOTATED TRAINING DATA FOR MACHINE LEARNING ENABLED IMAGE SEGMENTATION | TSAI, TSUNG YIN | 107d overdue |
| 17806252 | INHALER DEVICES, MEDICATION FORMULATIONS USED THEREWITH AND METHODS OF MANUFACTURE | RUDDIE, ELLIOT S | 44d overdue |
| 18482264 | MACHINE LEARNING-BASED PREDICTION OF TREATMENT REQUIREMENTS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) | SORRIN, AARON JOSEPH | 32d overdue |
| 18744107 | PREDICTING OPTIMAL TREATMENT REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) PATIENTS USING MACHINE LEARNING | JACKSON, JORDAN L | 27d |
| 18328278 | AUTOMATED SCREENING FOR DIABETIC RETINOPATHY SEVERITY USING COLOR FUNDUS IMAGE DATA | GEBRESLASSIE, WINTA | 33d |
| Client (Assignee) | Pending OAs |
|---|---|
| Roche | 3 |
| GENENTECH, INC. | 3 |
| Art Unit | Apps |
|---|---|
| 2857 | 1 |
| 2656 | 1 |
| 2672 | 1 |
| 2661 | 1 |
| 2677 | 1 |
| 3785 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18744107 | PREDICTING OPTIMAL TREATMENT REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) PATIENTS USING MACHINE LEARNING | Hoffmann-La Roche, Inc. | JACKSON, JORDAN L | 2857 | §103 | Final Rejection | 27d | Pending | Jun 14, 2024 |
| 18536174 | HIERARCHICAL WORKFLOW FOR GENERATING ANNOTATED TRAINING DATA FOR MACHINE LEARNING ENABLED IMAGE SEGMENTATION | Genentech, Inc. | TSAI, TSUNG YIN | 2656 | §103 | Non-Final OA | 107d overdue | Pending | Dec 11, 2023 |
| 18482264 | MACHINE LEARNING-BASED PREDICTION OF TREATMENT REQUIREMENTS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) | Hoffmann-La Roche, Inc. | SORRIN, AARON JOSEPH | 2672 | §103 | Non-Final OA | 32d overdue | Pending | Oct 06, 2023 |
| 18482237 | TREATMENT OUTCOME PREDICTION FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION USING BASELINE CHARACTERISTICS | Genentech, Inc. | WINDSOR, COURTNEY J | 2661 | §103 | Final Rejection | 31d overdue | Pending | Oct 06, 2023 |
| 18328278 | AUTOMATED SCREENING FOR DIABETIC RETINOPATHY SEVERITY USING COLOR FUNDUS IMAGE DATA | Hoffmann La-Roche Inc. | GEBRESLASSIE, WINTA | 2677 | §103 | Final Rejection | 33d | Pending | Jun 02, 2023 |
| 17806252 | INHALER DEVICES, MEDICATION FORMULATIONS USED THEREWITH AND METHODS OF MANUFACTURE | Genentech, Inc. | RUDDIE, ELLIOT S | 3785 | §103 | Non-Final OA | 44d overdue | Pending | Jun 09, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial